Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-13T03:30:04.355Z Has data issue: false hasContentIssue false

Allergen immunotherapy in ENT: historical perspective

Published online by Cambridge University Press:  31 May 2006

D. S. Kim
Affiliation:
Department of Otolaryngology, Queen Elizabeth Hospital, Birmingham, UK.
A. B. Drake-Lee
Affiliation:
Department of Otolaryngology, Queen Elizabeth Hospital, Birmingham, UK.

Abstract

The origins of immunology and allergy are founded upon the early 19th century microbiological studies of Jenner and Pasteur. It was discovered that the immune system could cause harm. The subspecialty of allergy began with the coining of the term by Von Pirquet in 1906 to describe disorders resulting from hyper-reaction to normally innocuous environmental agents.

Understanding the scientific basis of the immune system and allergy allowed Noon and Freeman, and later Cooke, to develop allergen immunotherapy. Initially the technique was crude, but with the subsequent key discovery of IgE, more accurate methods of diagnosis (such as the radioallergosorbent test (RAST)) and treatment ensued. The efficacy of specific immunotherapy has been demonstrated by many double-blind trials culminating in the WHO position paper.

DNA recombinant technology has provided detailed molecular understanding of allergic disorders, which has resulted in several novel methods of immunotherapy that are potentially safer and more effective. Use of recombinant allergens, T-cell peptides, DNA vaccination with CpG motifs or plasmid vectors and anti-IgE strategies with monoclonal antibodies are showing promise.

Type
Research Article
Copyright
© Royal Society of Medicine Press Limited 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)